242 related articles for article (PubMed ID: 23954383)
1. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.
Weinberger EE; Isakovic A; Scheiblhofer S; Ramsauer C; Reiter K; Hauser-Kronberger C; Thalhamer J; Weiss R
Vaccine; 2013 Dec; 31(51):6113-21. PubMed ID: 23954383
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
3. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy.
Scheiblhofer S; Stoecklinger A; Gruber C; Hauser-Kronberger C; Alinger B; Hammerl P; Thalhamer J; Weiss R
Mol Immunol; 2007 Mar; 44(8):1879-87. PubMed ID: 17070909
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a.
Hartl A; Hochreiter R; Stepanoska T; Ferreira F; Thalhamer J
Allergy; 2004 Jan; 59(1):65-73. PubMed ID: 14674936
[TBL] [Abstract][Full Text] [Related]
5. Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination.
Zhang F; Huang G; Hu B; Song Y; Shi Y
Clin Vaccine Immunol; 2011 May; 18(5):807-14. PubMed ID: 21346053
[TBL] [Abstract][Full Text] [Related]
6. Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.
Roesler E; Weiss R; Weinberger EE; Fruehwirth A; Stoecklinger A; Mostböck S; Ferreira F; Thalhamer J; Scheiblhofer S
J Allergy Clin Immunol; 2009 Nov; 124(5):1070-7.e1-11. PubMed ID: 19665781
[TBL] [Abstract][Full Text] [Related]
7. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
8. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
9. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
[TBL] [Abstract][Full Text] [Related]
11. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.
Hattinger E; Scheiblhofer S; Roesler E; Thalhamer T; Thalhamer J; Weiss R
J Immunol Res; 2015; 2015():797421. PubMed ID: 26557723
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U
Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169
[TBL] [Abstract][Full Text] [Related]
14. Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy.
Repa A; Wild C; Hufnagl K; Winkler B; Bohle B; Pollak A; Wiedermann U
Clin Exp Immunol; 2004 Jul; 137(1):12-8. PubMed ID: 15196238
[TBL] [Abstract][Full Text] [Related]
15. Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.
Jacquet A; Magi M; Haumont M; Jurado M; Garcia L; Bollen A
Clin Exp Allergy; 2003 Feb; 33(2):218-25. PubMed ID: 12580915
[TBL] [Abstract][Full Text] [Related]
16. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses.
Jenmalm MC; Björkstén B; Macaubas C; Holt BJ; Smallacombe TB; Holt PG
Pediatr Allergy Immunol; 1999 Aug; 10(3):168-77. PubMed ID: 10565557
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.
Linhart B; Narayanan M; Focke-Tejkl M; Wrba F; Vrtala S; Valenta R
Clin Exp Allergy; 2014 Feb; 44(2):278-87. PubMed ID: 24447086
[TBL] [Abstract][Full Text] [Related]
18. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
19. Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.
Hufnagl K; Focke M; Gruber F; Hufnagl P; Loupal G; Scheiner O; Wiedermann U
Clin Exp Allergy; 2008 Jul; 38(7):1192-202. PubMed ID: 18462454
[TBL] [Abstract][Full Text] [Related]
20. Bovine Holo-Beta-Lactoglobulin Cross-Protects Against Pollen Allergies in an Innate Manner in BALB/c Mice: Potential Model for the Farm Effect.
Afify SM; Pali-Schöll I; Hufnagl K; Hofstetter G; El-Bassuoni MA; Roth-Walter F; Jensen-Jarolim E
Front Immunol; 2021; 12():611474. PubMed ID: 33746954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
